Della Chà Alessandro

Della Chà Alessandro appears in our data through filings on Acacia Pharma Group shares, published by FSMA. In total, 3 filings cover trades dated from 30 June 2021 to 29 December 2021.

No open-market sale appears; the market trades are 3 purchases worth €19k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 1 purchase and no sales on the market.

Half of the purchases are above €6,427 and half below. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 7 January 2022 came the latest disclosure, an open-market purchase for €6,427 in Acacia Pharma Group. Typically, a trade is published a median of 12 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from FSMA disclosures alone and does not predict where the share price will go.